Rewalk Robotics

Shares medical device maker ReWalk Robotics dropped 19 percent at Tuesday's open after the company reported a loss of $5.8 million with $9.1 million in cash left on its balance sheet.

Shares of ReWalk Robotics dove by about one-third Tuesday as the company wasn't able to provide a full second-quarter financial statement and a delay in the closing of an investment.

Thanks to a revision of a U.S. Department of Veterans Affairs policy, injured veterans now have expanded access to exoskeleton systems from Marlborough medical device maker ReWalk Robotics.

ReWalk Robotics hopes to offer its robotic exoskeleton suit for stroke patients by July 2019, as five institutions approve clinical study of its device.

Marlborough medical robotic device firm ReWalk Robotics is now validated as a medical aid company in Germany.

Marlborough medical device manufacturer ReWalk Robotics has launched a clinical study of its robotic suit for the rehabilitation of stroke victims with lower limb disability.

Marlborough-headquartered ReWalk Robotics recorded a $24.7-million loss in 2017, but scored a $20-million investment from a Chinese group this week.

Two office buildings in Marlborough, including the U.S. home of ReWalk Robotics, have been sold to Oxford-based Minardi Limited Partnership for more than $13 million as the property management firm extends its reach into the MetroWest region.

Israeli medical device manufacturer ReWalk Robotics, with its U.S. offices in Marlborough, announced on Friday plans to raise $7.2 million in part to fund development of its new lightweight exoskeleton.

ReWalk Robotics Ltd., a manufacturer of robotic exoskeletons for those with spinal cord injuries, saw a 24-percent growth in revenue in the third quarter while posting a net loss of $5.8 million.